Ad Header

PharmaLive

Slogan

The Pulse of the Pharmaceutical Industry

Pfizer receives subpoenas in U.S. intravenous saline solution probe

Written by: | no-reply@reuters.com | Dated: Wednesday, April 19th, 2017

 

Pfizer Inc said on Wednesday that the company had received grand jury subpoenas from the U.S. Justice Department amid an antitrust investigation focused on drugmakers that market intravenous saline solution.

Pfizer disclosed the subpoenas in a statement a day after ICU Medical Inc, which recently acquired the company’s global infusion therapy business, on Tuesday said it had received a similar subpoena related to intravenous solutions.

 

(Reporting by Nate Raymond in Boston)

 

Reuters source:

http://www.reuters.com/article/us-pfizer-antitrust-idUSKBN17L1XT

Ad Right Top

MedAdNews

Extensive pharmaceutical business and marketing intelligence. For back issues, please contact MDAD@kmpsgroup.com.

October 2017 Focus: Manufacturer of the Year, Top 50 Pharma, HBA and more!

Subscribe

Ad Right Bottom

Main Navigation